13D/13G Filings - Omega Fund IV L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-11-14
08:35 am
Sale		2024-09-3013GReplimune Group, Inc.
REPL		Omega Fund IV L.P.2,709,991
4.000%		-540,000decrease
(-16.62%)		Filing
History
2024-02-14
4:44 pm
Sale		2023-12-3113GReplimune Group, Inc.
REPL		Omega Fund IV L.P.3,249,991
5.500%		-360,487decrease
(-9.98%)		Filing
History
2023-02-13
4:49 pm
Sale		2022-12-3113GReplimune Group, Inc.
REPL		Omega Fund IV L.P.3,610,478
7.200%		-1,445,074decrease
(-28.58%)		Filing
History
2022-02-14
3:18 pm
Sale		2021-12-3113GReplimune Group, Inc.
REPL		Omega Fund IV L.P.5,055,552
10.600%		-274,231decrease
(-5.15%)		Filing
History
2021-02-12
2:32 pm
Sale		2020-12-3113GESSA Pharma Inc.
EPIX		Omega Fund IV L.P.777,996
2.300%		-1,004,155decrease
(-56.35%)		Filing
History
2020-08-06
4:47 pm
Purchase		2020-07-2813GAlpine Immune Sciences, Inc.
ALPN		Omega Fund IV L.P.1,670,370
6.900%		1,670,370increase
(New Position)		Filing
History
2020-02-14
1:14 pm
Purchase		2019-12-3113GReplimune Group, Inc.
REPL		Omega Fund IV L.P.5,329,783
16.500%		226,328increase
(+4.43%)		Filing
History
2020-02-14
12:01 pm
Sale		2019-12-3113GESSA Pharma Inc.
EPIX		Omega Fund IV L.P.1,782,151
8.600%		-20,520,878decrease
(-92.01%)		Filing
History
2020-02-14
11:02 am
Unchanged		2019-12-3113GTelesis Bio, Inc.
TBIO		Omega Fund IV L.P.135,422
4.000%		0
(Unchanged)		Filing
History